Biochemical and immunopathological changes in experimental neurotoxocariasis

Molecular and Biochemical Parasitology

Volumn 172, Issue 1, 2010, Pages 1-8

  Othman, Ahmad A ^a   Abdel Aleem, Ghada A ^a   Saied, Eman M ^a   Mayah, Wael W ^a   Elatrash, Afaf M ^b  

^a TANTA UNIVERSITY   (Egypt)

^b Tanta University   (Egypt)

Author keywords

CNS; Cytokines; GFAP; INOS; Neurotoxocariasis; Neurotransmitters; Toxocara canis

Indexed keywords

4 AMINOBUTYRIC ACID; CYTOKINE; DOPAMINE; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTAMIC ACID; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 6; NEUROTRANSMITTER; NORADRENALIN; SEROTONIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CELL ACTIVATION; CHEMICAL ANALYSIS; CONTROLLED STUDY; EXPERIMENTAL INFECTION; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOLOGY; LARVA; MALE; MOUSE; NEUROTOXOCARIASIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TOXOCARA CANIS; TOXOCARIASIS;

ANIMALS; BRAIN; BRAIN CHEMISTRY; CENTRAL NERVOUS SYSTEM HELMINTHIASIS; CYTOKINES; HISTOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; LARVA; MICE; MICROSCOPY; NEUROTRANSMITTER AGENTS; TOXASCARIASIS; TOXOCARA CANIS;

ANIMALIA; MUS; TOXOCARA; TOXOCARA CANIS;

EID: 77952542300     PISSN: 01666851     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molbiopara.2010.03.006     Document Type: Article

References (46)

1. Magnaval J.F., Glickman L.T., Dorchies P., Morassin B. Highlights of human toxocariasis. Korean J Parasitol 2003, 39:1-11.
2. Vidal J.E., Sztajnbok J., Seguro A.C. Eosinophilic meningoencephalitis due to Toxocara canis. Case report and review of literature. Am J Trop Med Hyg 2003, 69:341-343.
3. Robinson A., Tannier C., Magnaval J.F. Toxocara canis meningoradiculitis. Rev Neurol (Paris) 2002, 158:351-353.
4. Goffette S., Jeanjean A.P., Bigaignon G., Sindic C.J. Eosinophilic pleocytosis and myelitis related to Toxocara canis infection. Eur J Neurol 2000, 67:703-706.
5. Arpino C., Gattinara G.C., Piergili D., Curatolo P. Toxocara infection and epilepsy in children: a case-control study. Epilepsia 1990, 31:33-36.
6. Worely G., Green J.A., Frothingham T.E. Toxocara canis infection. Clinical and epidemiological association with seropositivity in Kindergarten children. J Infect Dis 1984, 149:591-597.
7. Taylor M.R., Keane C.T., O'Connor P., Mulvihill E., Holland C. The expanded spectrum of toxocaral disease. Lancet 1988, 1:692-695.
8. Finsterer J., Auer H. Neurotoxocarosis. Rev Inst Med Trop Sao Paulo 2007, 49:279-287.
9. Pinelli E., Brandes S., Dormans J., Fonville M., Hamilton C.M., der Giessen J. Toxocara canis: effect of inoculum size on pulmonary pathology and cytokine expression in BALB/c mice. Exp Parasitol 2007, 115:76-82.
10. Hamilton C.M., Brandes S., Holland C.V., Pinelli E. Cytokine expression in the brains of Toxocara canis-infected mice. Parasite Immunol 2008, 30:181-185.
11. Stibb H.H., Curtis D.A. Neurochemical changes in experimental African trypanosomiasis in voles and mice. Ann Trop Med Parasitol 1987, 81:673-679.
12. Webster J.P. The effect of Toxoplasma gondii on animal behavior: playing cat and mouse. Schizophr Bull 2007, 33:752-756.
13. Abdel Ghafar A.E., El Kowrany S.E., Salem S.A., Menaisy A.A., Fadel W.A., Awara W.M. Effect of some parasitic infections on neurotransmitters in the brain of experimentally infected mice before and after treatment. J Egypt Soc Parasitol 1996, 26:497-508.
14. Carson M.J., Walter B. The cellular response in neuroinflammation: the role of leukocytes, microglia and astrocytes in neuronal death and survival. Clinic Neurosci Res 2006, 6:237-245.
15. Liao C.W., Cho W.L., Kao T.C., Su K.E., Lin Y.H., Fan C.K. Blood-brain barrier impairment with enhanced SP, NK-1R, GFAP and claudin-5 expressions in experimental cerebral toxocariasis. Parasite Immunol 2008, 30:525-534.
16. Kayes S.G., Oaks J.A. Effect of inoculum size and length of infection on the distribution of Toxocara canis larvae in the mouse. Am Soc Trop Med Hyg 1976, 25:573-580.
17. Erdó S.L. Postmortem increase of GABA levels in peripheral rat tissues: prevention by 3-mercapto-propionic acid. J Neural Transm 1984, 60:303-314.
18. Kema I.P., de Vries E.G., Slooff M.J., Biesma B., Muskiet F.A. Serotonin, catecholamine, histamine, and their metabolites in urine, platelets, and tumor tissue of patients with carcinoid tumors. Clin Chem 1994, 40:86-95.
19. Donzanti B.A., Yamamoto B.K. An improved and rapid HPLC-EC method for the isocratic separation of amino acid neurotransmitters from brain tissue and microdialysis perfusates. Life Sci 1988, 43:913-922.
20. Schlumpf M., Lichtensteiger W., Langemann H., Waser P.G., Hefti F. A fluorimetric micromethod for the simultaneous determination of serotonin, noradrenaline and dopamine in milligram amounts of brain tissue. Biochem Pharmacol 1974, 23:2337-2346.
21. Vatassery G.T., Sheridan M.A., Krezowski A.M. Spectrophotofluorometry of serotonin in blood platelets. Clin Chem 1981, 27:328.
22. Maneerat Y., Viriyavejakul P., Punpoowong B., et al. Inducible nitric oxide synthase expression is increased in the brain in fatal cerebral malaria. Histopathology 2000, 37:269-277.
23. Cox D.M., Holland C.V. Relationship between three intensity levels of Toxocara canis larvae in the brain and effects on exploration, anxiety, learning and memory in the murine host. J Helminthol 2001, 75:33-41.
24. Hamilton C.M., Stafford P., Pinelli E., Holland C.V. A murine model for cerebral toxocariasis: characterization of host susceptibility and behaviour. Parasitology 2006, 132:791-801.
25. Marmor M., Glickman L.T., Shofer F., et al. Toxocara canis infection of children; epidemiologic and neuropsychologic findings. Am J Public Health 1987, 77:554-559.
26. Bächli H., Minet J.C., Gratzl O. Cerebral toxocariasis: a possible cause of epileptic seizure in children. Childs Nerv Syst 2004, 20:468-472.
27. Good B., Holland C.V., Stafford P. The influence of inoculum size and time post-infection on the number and position of Toxocara canis larvae recovered from the brains of outbred CD1 mice. J Helminthol 2001, 75:175-181.
28. Scheid R., Jentzsch R.T., Schroeter M.L. Cognitive dysfunction, urinary retention, and a lesion in the thalamus - beware of possible toxocariasis of the central nervous system. Clin Neurol Neurosurg 2008, 110:1054-1057.
29. Hill I.R., Denham D.A., Scholtz C.L. Toxocara canis larvae in the brain of a British Child. Trans R Soc Trop Med Hyg 1985, 79:351-354.
30. Barone F.C., Kilgore K.S. Role of inflammation and cellular stress in brain injury and central nervous system diseases. Clin Neurosci Res 2006, 6:329-356.
31. Brown H., Turner G., Rogerson S., et al. Cytokine expression in the brain in human cerebral malaria. J Infect Dis 1999, 180:1742-1746.
32. Gimenez F., Barraud de Lagerie S., Fernandez C., Pino P., Mazier D. Tumour necrosis factor alpha in the pathogenesis of cerebral malaria. Cell Mol Life Sci 2003, 60:1623-1635.
33. Turrin N.P., Plata-Salaman C.R. Cytokine-cytokine interactions and the brain. Brain Res Bull 2000, 51:3-9.
34. Swartz K.R., Liu F., Sewell D., et al. Interleukin-6 promotes post-traumatic healing in the central nervous system. Brain Res 2001, 896:86-95.
35. Suzuki S., Tanaka K., Onawa S., et al. Temporal profile and cellular localization of interleukin-6 protein after focal cerebral ischemia in rats. J Cereb Blood Flow Metab 1999, 19:1256-1262.
36. Dvorak F., Martinez-Torres F., Sellner J., et al. Experimental herpes simplex virus encephalitis: a long-term study of interleukin-6 expression in mouse brain tissue. Neurosci Lett 2004, 367:289-292.
37. Song C., Lin A., Bonaccorso S., et al. The inflammatory response system and the availability of plasma tryptophan in patients with primary sleep disorders and major depression. J Affect Disord 1998, 49:211-219.
38. Fan C.K., Lin Y.H., Hung C.C., Chang S.F., Su K.E. Enhanced inducible nitric oxide synthase expression and nitrotyrosine accumulation in experimental granulomatous hepatitis caused by Toxocara canis in mice. Parasite Immunol 2004, 26:273-281.
39. Lin S.M., Liao C.W., Lin Y.H., Lee C.C., Kao T.C., Fan C.K. Inducible nitric oxide synthase inhibition influenced granuloma formation with suppressed collagen expression in myositis caused by Toxocara canis in mice. Parasitol Res 2008, 102:577-585.
40. Gargili A., Demirci C., Kandil A., Cetinkaya H., Atukeren P., Gümüştaş M.K. In vivo inhibition of inducible nitric oxide and evaluation of the brain tissue damage induced by Toxocara canis larvae in experimentally infected mice. Chin J Physiol 2004, 47:189-196.
41. Bloom F.E. Neurotransmission and the central nervous system. Goodman and Gilman's the pharmacological basis of therapeutics 2001, McGraw-Hill (Medical Publishing division), USA. 10th ed. J.G. Hardman, L.E. Limbind, A.G. Gilman (Eds.).
42. Desarro G., Dipaola E.D., Desarro A., Vidal M.J. l-arginine potentiates excitatory amino acid-induced seizures elicited in the deep prepiriform cortex. Eur J Pharm 1993, 230:151-158.
43. Jang S., Suh S.H., Yoo H.S., Lee Y.M., Oh S. Changes in iNOS, GFAP and NR1 expression in various brain regions and elevation of sphingosine-1-phosphate in serum after immobilized stress. Neurochem Res 2008, 33:842-851.
44. James P., Emma E., Jon G. Monitoring reactive gliosis in 3-dimensional astrocyte cultures; a model of spinal cord damage. Neuroscience 2008: 38th annual meeting of the Society for Neuroscience 2008, 15-19.
45. Johson J.D., Campisi J., Sharkey C.M., et al. Catecholamines mediates stress-induced increases in peripheral and central inflammatory cytokines. Neuroscience 2005, 135:1295-1307.
46. Henriquez S.A., Brett R., Alexander J., Pratt J., Roberts C.W. Neuropsychiatric disease and Toxoplasma gondii. Neuro Endocrinol Lett 2005, 26:480-486.